EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Perioperative complications of arteriovenous tirofiban administration versus oral dual antiplatelet therapy for stent‐assisted embolization treated aneurysmal subarachnoid hemorrhage: A retrospective, controlled cohort analysis

Kaishan Wang, Yujie Chen, Yao Xu, Chen Yang, Zhaopan Lai, Binbin Tan, Gang Zhu, Hongping Miao

Brain and Behavior · 2024-02 · 14 (2)

DOI: 10.1002/brb3.3439 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain and Behavior, online erschienen am 26.02.2024. Verfasst von Kaishan Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China. Hauptthemen laut MEDLINE: Subarachnoid Hemorrhage, Intracranial Aneurysm. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science-Health Joint Medical Scientific Research Project of Chongqing, Chongqing Talents Projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Major perioperative complications of stent‐assisted embolization treated for aneurysmal subarachnoid hemorrhage patients include the formation of thromboembolic events (TEs) and hemorrhagic events (HEs), for which antiplatelet protocols play a key role.

Methods

We conducted a single‐center retrospective analysis to compare the differences between arteriovenous tirofiban administration with traditional oral dual antiplatelet therapy (DAPT). A total of 417 consecutive patients were enrolled. General clinical characteristics, as well as the perioperative ischemic and hemorrhagic events, were retracted in digital documents. Logistic regression was conducted to identify both risk and protective factors of perioperative TEs and HEs.

Results

Perioperative TEs occurred in 21 patients, with an overall perioperative TEs rate of approximately 5.04%; among these patients, the incidence of perioperative TEs in the tirofiban group was less than that in the DAPT group. Additionally, 66 patients developed perioperative HEs, with an incidence of approximately 15.83%; among these patients, the incidence of perioperative HEs was less than that in the DAPT group. No significant differences were seen between the two groups in terms of the mRS score at the time of discharge.

Conclusion

This study indicated that an improved perioperative antiplatelet drug tirofiban was an independent protective factor for perioperative TEs in stent‐assisted embolization of ruptured intracranial aneurysms, but it did not impart an elevated risk of perioperative HEs and had no significant effects on the near‐term prognosis of the patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Subarachnoid HemorrhageIntracranial AneurysmHumansTirofibanPlatelet Aggregation InhibitorsRetrospective StudiesStentsTreatment Outcome

Stichwörter der Autor:innen

aneurysmal subarachnoid hemorrhagedual antiplatelet therapyperioperative complicationsstent-assisted embolizationtirofiban

Substanzen

TirofibanPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Department of Neurosurgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Chongqing Clinical Research Center for Neurosurgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Chongqing Key Laboratory of Precision Neuromedicine and Neuroregeneration, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.

Förderung

  • National Natural Science Foundation of China
  • Science-Health Joint Medical Scientific Research Project of Chongqing
  • Chongqing Talents Projects

Zitieren

APA

Wang, K., Chen, Y., Xu, Y., Yang, C., Lai, Z., Tan, B., Zhu, G., & Miao, H. (2024). Perioperative complications of arteriovenous tirofiban administration versus oral dual antiplatelet therapy for stent‐assisted embolization treated aneurysmal subarachnoid hemorrhage: A retrospective, controlled cohort analysis. Brain and Behavior, 14(2). https://doi.org/10.1002/brb3.3439

Vancouver

Wang K, Chen Y, Xu Y, Yang C, Lai Z, Tan B, et al. Perioperative complications of arteriovenous tirofiban administration versus oral dual antiplatelet therapy for stent‐assisted embolization treated aneurysmal subarachnoid hemorrhage: A retrospective, controlled cohort analysis. Brain and Behavior. 2024;14(2). doi:10.1002/brb3.3439

BibTeX
@article{Wang2024,
  author = {Wang, Kaishan and Chen, Yujie and Xu, Yao and Yang, Chen and Lai, Zhaopan and Tan, Binbin and Zhu, Gang and Miao, Hongping},
  title = {Perioperative complications of arteriovenous tirofiban administration versus oral dual antiplatelet therapy for stent‐assisted embolization treated aneurysmal subarachnoid hemorrhage: A retrospective, controlled cohort analysis},
  journal = {Brain and Behavior},
  year = {2024},
  volume = {14},
  number = {2},
  doi = {10.1002/brb3.3439}
}
Kostenlos starten →